Company name: Joint Venture (Canntab Therapeutics/Queensland Bauxite)
Description: Distributor of pharmaceutical-grade medical cannabis drug in Australia and Asia.
Year founded: 2018
Industry: Healthcare | Group: Healthcare Services | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was formed as a joint venture between Queensland Bauxite (ASX: QBL) and Canntab Therapeutics for an undisclosed amount on January 8, 2018.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: